Full enrollment in adult and adolescent SAFEGUARD cohorts sets up a pivotal 2027 data readout.
SAB Biotherapeutics, Inc. Common Stock (SABS) News
Latest headlines that mention SABS, newest first · each headline opens the original publisher
- Last price
- $3.10
- Day change
- +2.48%
- Next earnings
- —
SABS headlines
latest coverageNot much coverage yet. SABS has appeared in only a few headlines lately; new stories show up here as publishers cover it.
SABS news alerts
Get an alert by email or push when a new headline mentions SABS.
More news
News headlines aggregated from third-party publishers via public RSS feeds and tagged with the tickers they mention. Frenzy Capital does not publish or endorse the content; clicking a headline opens the original publisher in a new tab.